SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

H.C. Wainwright Reiterates Buy on Kala Pharmaceuticals, Raises Price Target to $14

H.C. Wainwright reiterates Kala Pharmaceuticals (NASDAQ:KALA) with a Buy and raises the price target from $13 to $14.

Benzinga · 05/08/2020 15:27

H.C. Wainwright reiterates Kala Pharmaceuticals (NASDAQ:KALA) with a Buy and raises the price target from $13 to $14.